Statin therapy in women

Menopause

Volumn 21, Issue 8, 2014, Pages 896-898

  Shufelt, Chrisandra L ^a   Manson, Joann E ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG SAFETY; FEMALE; HUMAN; LOW RISK POPULATION; MEDICAL SOCIETY; MEDICATION THERAPY MANAGEMENT; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HYPERLIPIDEMIAS; MENOPAUSE; MIDDLE AGED; WOMEN'S HEALTH;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MENOPAUSE; MIDDLE AGED; WOMEN'S HEALTH;

EID: 84904894234     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000317     Document Type: Article

References (10)

1. Cholesterol Treatment Trialists (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-1681
2. Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med 2012;172:909-919
3. Truong QA, Murphy SA, McCabe CH, Armani A, Cannon CP, TIMI Study Group. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circ Cardiovasc Qual Outcomes 2011;4:328-336
4. Ridker PM, MacFadyen JG, Fonseca FA, et al. JUPITER Study Group. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes 2009;2:616-623
5. Bukkapatnam RN, Gabler NB, Lewis WR. Statins for primary prevention of cardiovascular mortality in women: a systematic review and metaanalysis. Prev Cardiol 2010;13:84-90
6. Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Metaanalysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59(6):572-582. Erratum in. J Am Coll Cardiol 2012;59:1491
7. Cholesterol Treatment Trialists (CTT) Collaborators; Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: metaanalysis of individual data from 27 randomised trials. Lancet 2012; 380:581-590
8. Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med 2011;78:393-403
9. Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A metaanalysis. JAMA 2011;305:2556-2564
10. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines [published online ahead of print November 12, 2012]. Circulation.